相关实验视频
Updated: Jan 16, 2026

09:27
Generation of Fluorescent Protein Fusions in Candida Species
Published on: March 4, 2017
11.1K
一名患有慢性粘膜皮质候群症的儿童在STAT1中携带了一种新的功能获取突变
Yang Xiang1, Shuo Sun2, Hong Wang2
1Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250000, Shandong Province, P.R. China.
Journal of clinical immunology
|September 30, 2025
概括
一种新的STAT1 (信号转换器和转录激活器1) 功能增益突变导致了儿科患者的慢性粘膜皮肤候群病 (CMC). 像ruxolitinib这样的JAK抑制剂显示出治疗这种疾病的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 皮肤病学 皮肤病学
背景情况:
- 在STAT1 (信号转换器和转录激活器1) 中发生的生殖线异构性功能增益 (GOF) 突变会损害IL-17介导的免疫力.
- 这种损伤导致对慢性粘膜皮肤候群病 (CMC) 的易感性增加.
- 雅克抑制剂在控制STAT1-GOF突变方面已经证明了治疗效益.
研究的目的:
- 在患有CMC的儿科患者中识别和表征一种新的STAT1突变.
- 调查发现突变对免疫反应的功能影响.
- 在这种情况下,评估JAK抑制剂的治疗潜力.
主要方法:
- 整体外体测序 (WES) 和桑格测序用于突变检测.
- 路西法酶记者测定验证了STAT1突变的功能影响.
- 流细胞计评估了STAT1酸化,白细胞子集表型和细胞因子表达 (例如IL-17A).
主要成果:
- 在该患者身上,在STAT1中发现了一种新型异构合误解突变 (c.1078G>C,p.V360L).
- 功能分析证实这种突变是一种功能获取变异,具有增强的STAT1酸化.
- 患者表现出减少的CD4+T细胞,NK细胞和Th17细胞, IL-17A表达减少. 还观察到IgM和特定细胞因子水平的升高.
- 局部鲁克索利提尼布治疗证明了治疗疗效.
结论:
- 一个新的STAT1GOF突变与儿科患者的CMC有关,可能是通过损害IL-17免疫力.
- 需要进一步的研究才能充分阐明这种突变与CMC之间的机制联系.
- 鲁克索利提尼布为CMC提供了潜在的治疗策略,需要进一步的临床验证.
更多相关视频
相关概念视频
Cystic Fibrosis: Pathogenesis
722
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
722
Mismatch Repair
6.3K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.3K
Mismatch Repair
43.5K
Overview
43.5K
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
Mutations in Microorganisms
516
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
516
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K

